Skip to main content
U

UNIVERSAL BIOSENSORS INC. — Investor Relations & Filings

Ticker · UBI LEI · 9845006ABC71C514C696 ASX Manufacturing
Filings indexed 37 across all filing types
Latest filing 2025-08-21 Regulatory Filings
Country AU Australia
Listing ASX UBI

About UNIVERSAL BIOSENSORS INC.

https://universalbiosensors.com/

Universal Biosensors Inc. specializes in the research, development, and manufacture of electrochemical biosensor systems for point-of-care testing. The company leverages a proprietary technology platform to deliver rapid, accurate diagnostic results across various sectors, including healthcare and food and beverage. Its core product offerings include the Xprecia Prime system for coagulation monitoring and the Sentia platform, which provides automated laboratory-grade analysis for the wine industry, measuring parameters such as free sulfur dioxide, malic acid, and glucose. Universal Biosensors focuses on miniaturizing complex laboratory tests into portable, easy-to-use devices, utilizing multi-layer test strip architecture and sophisticated electrochemical detection methods to improve testing efficiency and accessibility in decentralized settings.

Recent filings

Filing Released Lang Actions
Suspension from Quotation 1 page 58.3KB
Regulatory Filings
2025-08-21 English
Trading Halt 2 pages 223.5KB
Regulatory Filings
2025-08-19 English
KPMG appointed as Voluntary Administrators 1 page 1
Regulatory Filings
2025-08-19 English
Funding Strategy Update 2 pages 166.7KB
Regulatory Filings
2025-08-17 English
Update on Funding Strategy 2 pages 172.1KB
Regulatory Filings
2025-08-06 English
Appendix 4D and Half Year Results - 30 June 2025 39 pages 684.6KB
Regulatory Filings
2025-08-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.